Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease

AS Abdelhamid, TJ Brown, JS Brainard… - Cochrane Database …, 2018 - cochranelibrary.com
Background Researchers have suggested that omega‐3 polyunsaturated fatty acids from
oily fish (long‐chain omega‐3 (LCn3), including eicosapentaenoic acid (EPA) and …

Omega-3 polyunsaturated fatty acids and their health benefits

F Shahidi, P Ambigaipalan - Annual review of food science and …, 2018 - annualreviews.org
Omega-3 polyunsaturated fatty acids (PUFAs) include α-linolenic acid (ALA; 18: 3 ω-3),
stearidonic acid (SDA; 18: 4 ω-3), eicosapentaenoic acid (EPA; 20: 5 ω-3) …

Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial

AA Kalstad, PL Myhre, K Laake, SH Tveit, EB Schmidt… - Circulation, 2021 - Am Heart Assoc
Background: High intake of marine n-3 polyunsaturated fatty acids (PUFA) has been
associated with reduced risk of cardiovascular events; however, this has not been confirmed …

[HTML][HTML] Marine n− 3 fatty acids and prevention of cardiovascular disease and cancer

JAE Manson, NR Cook, IM Lee… - … England Journal of …, 2019 - Mass Medical Soc
Background Higher intake of marine n− 3 (also called omega-3) fatty acids has been
associated with reduced risks of cardiovascular disease and cancer in several observational …

[HTML][HTML] Marine omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020

JK Innes, PC Calder - International journal of molecular sciences, 2020 - mdpi.com
The omega-3 (n-3) fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA), are found in seafood (especially fatty fish), supplements and concentrated …

Marine omega‐3 supplementation and cardiovascular disease: an updated meta‐analysis of 13 randomized controlled trials involving 127 477 participants

Y Hu, FB Hu, JAE Manson - Journal of the American Heart …, 2019 - Am Heart Assoc
Background Whether marine omega‐3 supplementation is associated with reduction in risk
of cardiovascular disease (CVD) remains controversial. Methods and Results This meta …

Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals

T Aung, J Halsey, D Kromhout, HC Gerstein… - JAMA …, 2018 - jamanetwork.com
Importance Current guidelines advocate the use of marine-derived omega-3 fatty acids
supplements for the prevention of coronary heart disease and major vascular events in …

Heart disease and stroke statistics—2016 update: a report from the American Heart Association

D Mozaffarian, EJ Benjamin, AS Go, DK Arnett… - circulation, 2016 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

VLDL cholesterol accounts for one-half of the risk of myocardial infarction associated with apoB-containing lipoproteins

M Balling, S Afzal, A Varbo, A Langsted… - Journal of the American …, 2020 - jacc.org
Abstract Background Plasma apolipoprotein B (apoB) is a composite measure of all apoB-
containing lipoproteins causing atherosclerotic cardiovascular disease; however, it is …

Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

YK Tham, BC Bernardo, JYY Ooi, KL Weeks… - Archives of …, 2015 - Springer
The onset of heart failure is typically preceded by cardiac hypertrophy, a response of the
heart to increased workload, a cardiac insult such as a heart attack or genetic mutation …